Browsing by Author Lu, Christine

Jump to: 0-9 A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
or enter first few letters:  
Showing results 1 to 11 of 11
Issue DateTitleAuthor(s)Citation
2018Long-term survival in trastuzumab-treated patients with HER2-positive metastatic breast cancer: real-world outcomes and treatment patterns in a whole-of-population Australian cohort (2001-2016)Houssami, Nehmat; Kiely, Belinda Emma; Lord, Sarah (Sally); Daniels, Benjamin; Lu, Christine; Pearson, Sallie-Anne; Ward, Robyn L; School of Public Health: Public Health; NH&MRC Clinical Trials Centre; NH&MRC Clinical Trials CentreLong-term survival in trastuzumab-treated patients with HER2-positive metastatic breast cancer: real-world outcomes and treatment patterns in a whole-of-population Australian cohort (2001-2016), Breast Cancer Research and Treatment, vol.171, 1, 2018,pp 151-159
2018Long-term survival in trastuzumab-treated patients with HER2-positive metastatic breast cancer: real-world outcomes and treatment patterns in a whole-of-population Australian cohort (2001-2016)Houssami, Nehmat; Kiely, Belinda Emma; Lord, Sarah (Sally); Daniels, Benjamin; Lu, Christine; Pearson, Sallie-Anne; Ward, Robyn L; School of Public Health: Public Health; NH&MRC Clinical Trials Centre; NH&MRC Clinical Trials CentreLong-term survival in trastuzumab-treated patients with HER2-positive metastatic breast cancer: real-world outcomes and treatment patterns in a whole-of-population Australian cohort (2001-2016), Breast Cancer Research and Treatment, vol.171, 1, 2018,pp 151-159
2018Long-term survival in trastuzumab-treated patients with HER2-positive metastatic breast cancer: real-world outcomes and treatment patterns in a whole-of-population Australian cohort (2001-2016)Houssami, Nehmat; Kiely, Belinda Emma; Lord, Sarah (Sally); Daniels, Benjamin; Lu, Christine; Pearson, Sallie-Anne; Ward, Robyn L; School of Public Health: Public Health; NH&MRC Clinical Trials Centre; NH&MRC Clinical Trials CentreLong-term survival in trastuzumab-treated patients with HER2-positive metastatic breast cancer: real-world outcomes and treatment patterns in a whole-of-population Australian cohort (2001-2016), Breast Cancer Research and Treatment, vol.171, 1, 2018,pp 151-159
2018Long-term survival in trastuzumab-treated patients with HER2-positive metastatic breast cancer: real-world outcomes and treatment patterns in a whole-of-population Australian cohort (2001-2016)Houssami, Nehmat; Kiely, Belinda Emma; Lord, Sarah (Sally); Daniels, Benjamin; Lu, Christine; Pearson, Sallie-Anne; Ward, Robyn L; School of Public Health: Public Health; NH&MRC Clinical Trials Centre; NH&MRC Clinical Trials CentreLong-term survival in trastuzumab-treated patients with HER2-positive metastatic breast cancer: real-world outcomes and treatment patterns in a whole-of-population Australian cohort (2001-2016), Breast Cancer Research and Treatment, vol.171, 1, 2018,pp 151-159
2018Long-term survival in trastuzumab-treated patients with HER2-positive metastatic breast cancer: real-world outcomes and treatment patterns in a whole-of-population Australian cohort (2001-2016)Houssami, Nehmat; Kiely, Belinda Emma; Lord, Sarah (Sally); Daniels, Benjamin; Lu, Christine; Pearson, Sallie-Anne; Ward, Robyn L; School of Public Health: Public Health; NH&MRC Clinical Trials Centre; NH&MRC Clinical Trials CentreLong-term survival in trastuzumab-treated patients with HER2-positive metastatic breast cancer: real-world outcomes and treatment patterns in a whole-of-population Australian cohort (2001-2016), Breast Cancer Research and Treatment, vol.171, 1, 2018,pp 151-159
2018Long-term survival in trastuzumab-treated patients with HER2-positive metastatic breast cancer: real-world outcomes and treatment patterns in a whole-of-population Australian cohort (2001-2016)Houssami, Nehmat; Kiely, Belinda Emma; Lord, Sarah (Sally); Daniels, Benjamin; Lu, Christine; Pearson, Sallie-Anne; Ward, Robyn L; School of Public Health: Public Health; NH&MRC Clinical Trials Centre; NH&MRC Clinical Trials CentreLong-term survival in trastuzumab-treated patients with HER2-positive metastatic breast cancer: real-world outcomes and treatment patterns in a whole-of-population Australian cohort (2001-2016), Breast Cancer Research and Treatment, vol.171, 1, 2018,pp 151-159
2018Long-term survival in trastuzumab-treated patients with HER2-positive metastatic breast cancer: real-world outcomes and treatment patterns in a whole-of-population Australian cohort (2001-2016)Houssami, Nehmat; Kiely, Belinda Emma; Lord, Sarah (Sally); Daniels, Benjamin; Lu, Christine; Pearson, Sallie-Anne; Ward, Robyn L; School of Public Health: Public Health; NH&MRC Clinical Trials Centre; NH&MRC Clinical Trials CentreLong-term survival in trastuzumab-treated patients with HER2-positive metastatic breast cancer: real-world outcomes and treatment patterns in a whole-of-population Australian cohort (2001-2016), Breast Cancer Research and Treatment, vol.171, 1, 2018,pp 151-159
2018Long-term survival in trastuzumab-treated patients with HER2-positive metastatic breast cancer: real-world outcomes and treatment patterns in a whole-of-population Australian cohort (2001-2016)Houssami, Nehmat; Kiely, Belinda Emma; Lord, Sarah (Sally); Daniels, Benjamin; Lu, Christine; Pearson, Sallie-Anne; Ward, Robyn L; School of Public Health: Public Health; NH&MRC Clinical Trials Centre; NH&MRC Clinical Trials CentreLong-term survival in trastuzumab-treated patients with HER2-positive metastatic breast cancer: real-world outcomes and treatment patterns in a whole-of-population Australian cohort (2001-2016), Breast Cancer Research and Treatment, vol.171, 1, 2018,pp 151-159
2018Long-term survival in trastuzumab-treated patients with HER2-positive metastatic breast cancer: real-world outcomes and treatment patterns in a whole-of-population Australian cohort (2001-2016)Houssami, Nehmat; Kiely, Belinda Emma; Lord, Sarah (Sally); Daniels, Benjamin; Lu, Christine; Pearson, Sallie-Anne; Ward, Robyn L; School of Public Health: Public Health; NH&MRC Clinical Trials Centre; NH&MRC Clinical Trials CentreLong-term survival in trastuzumab-treated patients with HER2-positive metastatic breast cancer: real-world outcomes and treatment patterns in a whole-of-population Australian cohort (2001-2016), Breast Cancer Research and Treatment, vol.171, 1, 2018,pp 151-159
2018Long-term survival in trastuzumab-treated patients with HER2-positive metastatic breast cancer: real-world outcomes and treatment patterns in a whole-of-population Australian cohort (2001-2016)Houssami, Nehmat; Kiely, Belinda Emma; Lord, Sarah (Sally); Daniels, Benjamin; Lu, Christine; Pearson, Sallie-Anne; Ward, Robyn L; School of Public Health: Public Health; NH&MRC Clinical Trials Centre; NH&MRC Clinical Trials CentreLong-term survival in trastuzumab-treated patients with HER2-positive metastatic breast cancer: real-world outcomes and treatment patterns in a whole-of-population Australian cohort (2001-2016), Breast Cancer Research and Treatment, vol.171, 1, 2018,pp 151-159
2013Trastuzumab therapy in Australia: Which patients with HER2+ metastatic breast cancer are assessed for cardiac function?Pearson, Sallie-Anne; Chen, Katie; Drew, A; Lu, Christine; Srasuebkul, Preeyaporn; Ward, Robyn; PharmacyTrastuzumab therapy in Australia: Which patients with HER2+ metastatic breast cancer are assessed for cardiac function?, The Breast, vol.22, 4, 2013,pp 482-487